Ressources

Strategies to Support Ontarians’ Capability, Opportunity, and Motivation for COVID‑19 Vaccination

Product: — Science Table

About Coronavirus Epidemiology Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: juin 23, 2021

Guidance and Jurisdictional Evidence Regarding The Use of Vaccine Passports

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: juin 21, 2021

Effectiveness of Incentives to Promote COVID‑19 Vaccine Uptake

Product: — Evidence Synthesis Network

Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: juin 17, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Dernière mise à jour: juin 15, 2021

Response to the Premier of Ontario

Product: — Science Table

Community & Social Services Future Planning Public Health & Implementation Public Health Policy Public Policy & Economic Impact

covid19-sciencetable.ca Dernière mise à jour: mai 29, 2021

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: mai 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 11, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Lay Summary

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 7, 2021